OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential drug therapies for the treatment of fibromyalgia
Kim Lawson
Expert Opinion on Investigational Drugs (2016) Vol. 25, Iss. 9, pp. 1071-1081
Open Access | Times Cited: 22

Showing 22 citing articles:

<p>Role of Melatonin in the Regulation of Pain</p>
Shanshan Xie, Wenguo Fan, Hongwen He, et al.
Journal of Pain Research (2020) Vol. Volume 13, pp. 331-343
Open Access | Times Cited: 54

Management of Fibromyalgia: An Update
Eric A. Jones, Farrah S. Asaad, Nishil Patel, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1266-1266
Open Access | Times Cited: 6

Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats
Gaia Favero, Valentina Trapletti, Francesca Bonomini, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1389-1389
Open Access | Times Cited: 54

The current treatment of fibromyalgia
José Oswaldo de Oliveira Júnior, Mauro Brito de Almeida
Brazilian Journal Of Pain (2018) Vol. 1, Iss. 3
Open Access | Times Cited: 51

Pharmacological interactions of sulforaphane and gabapentin in a murine fibromyalgia-like pain model
Ik-Yahalcab Zamora-Díaz, María Eva González-Trujano, David Martínez‐Vargas, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117929-117929
Open Access

Modulation of NMDA Receptor Activity in Fibromyalgia
Geoffrey Littlejohn, Emma Guymer
Biomedicines (2017) Vol. 5, Iss. 2, pp. 15-15
Open Access | Times Cited: 44

Impact of mast cells in fibromyalgia and low‐grade chronic inflammation: Can IL‐37 play a role?
Pio Conti, Carla Enrica Gallenga, A. Caraffa, et al.
Dermatologic Therapy (2019) Vol. 33, Iss. 1
Open Access | Times Cited: 26

Pharmacological management of fibromyalgia: a Bayesian network meta-analysis
Filippo Migliorini, Nicola Maffulli, Jörg Eschweiler, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 2, pp. 205-214
Closed Access | Times Cited: 14

Anti-hyperalgesic effect of Lippia grata leaf essential oil complexed with β-cyclodextrin in a chronic musculoskeletal pain animal model: Complemented with a molecular docking and antioxidant screening
Pollyana S. Siqueira-Lima, Renan Guedes de Brito, Heitor G. Araújo-Filho, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 91, pp. 739-747
Closed Access | Times Cited: 25

Patients’ perspective of the effectiveness and acceptability of pharmacological and non-pharmacological treatments of fibromyalgia
Sophie Taylor, Michael L. Steer, Simon Ashe, et al.
Scandinavian Journal of Pain (2018) Vol. 19, Iss. 1, pp. 167-181
Open Access | Times Cited: 25

Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial.
Mansoor Shakiba, Ehsan Moazen‐Zadeh, Ahmad Ali Noorbala, et al.
PubMed (2018) Vol. 8, Iss. 6, pp. 513-523
Closed Access | Times Cited: 20

Ambroxol for the treatment of fibromyalgia: science or fiction?
Kai‐Uwe Kern, Myriam Schwickert
Journal of Pain Research (2017) Vol. Volume 10, pp. 1905-1929
Open Access | Times Cited: 19

Review of Voltage-gated Calcium Channel α2δ Subunit Ligands for the Treatment of Chronic Neuropathic Pain and Insight into Structure-activity Relationship (SAR) by Pharmacophore Modeling
Yu‐Ting Chen, Qingqing Wu, Zhengsheng Jin, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 30, pp. 5097-5112
Closed Access | Times Cited: 9

Efficacy of cannabinoids in fibromyalgia: a literature review
Henry Jair Mayorga Anaya, María Paula Torres Ortiz, Daniel Hernando Flórez Valencia, et al.
Colombian Journal of Anesthesiology (2021)
Open Access | Times Cited: 12

New drugs or alternative therapy to blurring the symptoms of fibromyalgia—a patent review
Marlange A. Oliveira, Adriana Gibara Guimarães, Adriano Antunes de Souza Araújo, et al.
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 10, pp. 1147-1157
Closed Access | Times Cited: 12

Modulation of NMDA Receptor Activity in Fibromyalgia
Geoffrey Littlejohn, Emma Guymer
(2017)
Open Access | Times Cited: 8

Pharmacological Treatment of Fibromyalgia
Emma Guymer, Geoffrey Littlejohn
Springer eBooks (2021), pp. 33-52
Closed Access | Times Cited: 7

Aspectos clínicos e principais formas de tratamento para Fibromialgia - Revisão de Literatura
Samara Maria Lopes Costa, Mani Pacciulli Meyer Passos e Silva, Liliane Pereira Pinto, et al.
Research Society and Development (2020) Vol. 9, Iss. 11, pp. e729119495-e729119495
Open Access | Times Cited: 3

An Overview of the Methodologies and the Quality of Studies on Pharmacotherapy for the Treatment of Fibromyalgia
Cristiani Isabel Banderó Walker, Renata Ferraz Figueiredo, Alana Teles Costa, et al.
Current Rheumatology Reviews (2022) Vol. 18, Iss. 4, pp. 305-316
Closed Access | Times Cited: 2

Page 1

Scroll to top